Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Appointed director
ANTARES PHARMA, INC. (ATRS) Create: Alert

All | News | Filings
Date FiledTypeDescription
05/26/2022 4 ROCHE ROBERT P JR (Director) has filed a Form 4 on ANTARES PHARMA, INC.
Txns: Disposed/sold 118,392 shares @ $5.6, valued at $663k
Disposed/sold 49,425 shares @ $5.6, valued at $276.8k
Disposed/sold 20,000 options to buy @ $4.54, valued at $90.8k
Disposed/sold 61,930 options to buy @ $3.09, valued at $191.4k
Disposed/sold 99,395 options to buy @ $2.18, valued at $216.7k
Disposed/sold 150,000 options to buy @ $1.12, valued at $168k
Disposed/sold 80,318 options to buy @ $2.66, valued at $213.6k
Disposed/sold 76,548 options to buy @ $2.7, valued at $206.7k
Disposed/sold 46,729 options to buy @ $2.92, valued at $136.4k
Disposed/sold 58,246 options to buy @ $2.73, valued at $159k
Disposed/sold 48,542 options to buy @ $4.42, valued at $214.6k
05/26/2022 4 GUETH ANTON (Director) has filed a Form 4 on ANTARES PHARMA, INC.
Txns: Disposed/sold 386,132 shares @ $5.6, valued at $2.2M
Disposed/sold 1,800 shares @ $5.6, valued at $10.1k
Disposed/sold 79,645 shares @ $5.6, valued at $446k
Disposed/sold 61,930 options to buy @ $3.09, valued at $191.4k
Disposed/sold 99,395 options to buy @ $2.18, valued at $216.7k
Disposed/sold 150,000 options to buy @ $1.12, valued at $168k
Disposed/sold 80,318 options to buy @ $2.66, valued at $213.6k
Disposed/sold 76,548 options to buy @ $2.7, valued at $206.7k
Disposed/sold 46,729 options to buy @ $2.92, valued at $136.4k
Disposed/sold 58,246 options to buy @ $2.73, valued at $159k
Disposed/sold 48,542 options to buy @ $4.42, valued at $214.6k
05/26/2022 4 Richardson Peter C (See Remarks) has filed a Form 4 on ANTARES PHARMA, INC.
Txns: Disposed/sold 36,199 shares @ $5.6, valued at $202.7k
Disposed/sold 14,414 shares @ $5.6, valued at $80.7k
Disposed/sold 59,179 options to buy @ $4.01, valued at $237.3k
Disposed/sold 69,037 options to buy @ $4.42, valued at $305.1k
05/26/2022 4 Smith Karen L. (Director) has filed a Form 4 on ANTARES PHARMA, INC.
Txns: Disposed/sold 54,193 shares @ $5.6, valued at $303.5k
Disposed/sold 25,452 shares @ $5.6, valued at $142.5k
Disposed/sold 20,000 options to buy @ $3.72, valued at $74.4k
Disposed/sold 46,729 options to buy @ $2.92, valued at $136.4k
Disposed/sold 58,246 options to buy @ $2.73, valued at $159k
Disposed/sold 48,542 options to buy @ $4.42, valued at $214.6k
05/26/2022 4 JACOB LEONARD S (Director) has filed a Form 4 on ANTARES PHARMA, INC.
Txns: Disposed/sold 138,901 shares @ $5.6, valued at $777.8k
Disposed/sold 31,674 shares @ $5.6, valued at $177.4k
Disposed/sold 123,860 options to buy @ $3.09, valued at $382.7k
Disposed/sold 198,789 options to buy @ $2.18, valued at $433.4k
Disposed/sold 300,000 options to buy @ $1.12, valued at $336k
Disposed/sold 160,636 options to buy @ $2.66, valued at $427.3k
Disposed/sold 153,097 options to buy @ $2.7, valued at $413.4k
Disposed/sold 73,431 options to buy @ $2.92, valued at $214.4k
Disposed/sold 77,662 options to buy @ $2.73, valued at $212k
Disposed/sold 60,407 options to buy @ $4.42, valued at $267k
05/26/2022 4 GRAHAM PETER J (See Remarks) has filed a Form 4 on ANTARES PHARMA, INC.
Txns: Disposed/sold 414,470 shares @ $5.6, valued at $2.3M
Disposed/sold 202,139 shares @ $5.6, valued at $1.1M
Disposed/sold 124,234 shares @ $5.6, valued at $695.7k
Disposed/sold 125,000 options to buy @ $2.29, valued at $286.3k
Disposed/sold 212,900 options to buy @ $1.12, valued at $238.4k
Disposed/sold 217,725 options to buy @ $2.66, valued at $579.1k
Disposed/sold 177,453 options to buy @ $2.7, valued at $479.1k
Disposed/sold 170,227 options to buy @ $2.92, valued at $497.1k
Disposed/sold 254,165 options to buy @ $2.73, valued at $693.9k
Disposed/sold 163,963 options to buy @ $4.42, valued at $724.7k
05/26/2022 4 GARRITY THOMAS J (Director) has filed a Form 4 on ANTARES PHARMA, INC.
Txns: Disposed/sold 224,406 shares @ $5.6, valued at $1.3M
Disposed/sold 25,452 shares @ $5.6, valued at $142.5k
Disposed/sold 61,930 options to buy @ $3.09, valued at $191.4k
Disposed/sold 99,395 options to buy @ $2.18, valued at $216.7k
Disposed/sold 80,318 options to buy @ $2.66, valued at $213.6k
Disposed/sold 76,548 options to buy @ $2.7, valued at $206.7k
Disposed/sold 46,729 options to buy @ $2.92, valued at $136.4k
Disposed/sold 58,246 options to buy @ $2.73, valued at $159k
Disposed/sold 48,542 options to buy @ $4.42, valued at $214.6k
05/26/2022 4 Powell Fred M (Executive Vice President & CFO) has filed a Form 4 on ANTARES PHARMA, INC.
Txns: Disposed/sold 587,014 shares @ $5.6, valued at $3.3M
Disposed/sold 204,022 shares @ $5.6, valued at $1.1M
Disposed/sold 124,234 shares @ $5.6, valued at $695.7k
Disposed/sold 150,000 options to buy @ $1.76, valued at $264k
Disposed/sold 217,725 options to buy @ $2.66, valued at $579.1k
Disposed/sold 177,453 options to buy @ $2.7, valued at $479.1k
Disposed/sold 181,575 options to buy @ $2.92, valued at $530.2k
Disposed/sold 254,165 options to buy @ $2.73, valued at $693.9k
Disposed/sold 163,963 options to buy @ $4.42, valued at $724.7k
05/26/2022 4 APPLE ROBERT F (President and CEO) has filed a Form 4 on ANTARES PHARMA, INC.
Txns: Disposed/sold 1,876,693 shares @ $5.6, valued at $10.5M
Disposed/sold 611,667 shares @ $5.6, valued at $3.4M
Disposed/sold 374,099 shares @ $5.6, valued at $2.1M
Disposed/sold 21,658 options to buy @ $4.26, valued at $92.3k
Disposed/sold 56,300 options to buy @ $3.09, valued at $174k
Disposed/sold 288,786 options to buy @ $2.18, valued at $629.6k
Disposed/sold 773,700 options to buy @ $1.12, valued at $866.5k
Disposed/sold 725,751 options to buy @ $2.66, valued at $1.9M
Disposed/sold 591,510 options to buy @ $2.7, valued at $1.6M
Disposed/sold 567,423 options to buy @ $2.92, valued at $1.7M
Disposed/sold 776,617 options to buy @ $2.73, valued at $2.1M
05/26/2022 4 Volkart Carmen B (Director) has filed a Form 4 on ANTARES PHARMA, INC.
Txns: Disposed/sold 55,916 options to buy @ $3.48, valued at $194.6k
05/26/2022 4 Greenleaf Peter (Director) has filed a Form 4 on ANTARES PHARMA, INC.
Txns: Disposed/sold 30,220 shares @ $5.6, valued at $169.2k
Disposed/sold 49,425 shares @ $5.6, valued at $276.8k
Disposed/sold 20,000 options to buy @ $3.11, valued at $62.2k
Disposed/sold 46,729 options to buy @ $2.92, valued at $136.4k
Disposed/sold 58,246 options to buy @ $2.73, valued at $159k
Disposed/sold 48,542 options to buy @ $4.42, valued at $214.6k
03/04/2022 4 APPLE ROBERT F (President & CEO) has filed a Form 4 on ANTARES PHARMA, INC.
Txns: Granted 86,814 shares @ $0
Paid exercise price by delivering 37,695 shares @ $3.8, valued at $143.2k
03/04/2022 4 Powell Fred M (Executive Vice President & CFO) has filed a Form 4 on ANTARES PHARMA, INC.
Txns: Granted 27,780 shares @ $0
Paid exercise price by delivering 11,506 shares @ $3.8, valued at $43.7k
03/04/2022 4 GRAHAM PETER J (EVP General Counsel, Secretary) has filed a Form 4 on ANTARES PHARMA, INC.
Txns: Granted 26,044 shares @ $0
Paid exercise price by delivering 13,635 shares @ $3.8, valued at $51.8k
02/18/2022 4 GRAHAM PETER J (EVP General Counsel, Secretary) has filed a Form 4 on ANTARES PHARMA, INC.
Txns: Granted 23,068 shares @ $0
Paid exercise price by delivering 13,299 shares @ $3.66, valued at $48.7k
02/18/2022 4 Powell Fred M (Executive Vice President & CFO) has filed a Form 4 on ANTARES PHARMA, INC.
Txns: Granted 24,606 shares @ $0
Paid exercise price by delivering 11,496 shares @ $3.66, valued at $42.1k
02/18/2022 4 APPLE ROBERT F (President & CEO) has filed a Form 4 on ANTARES PHARMA, INC.
Txns: Granted 76,893 shares @ $0
Paid exercise price by delivering 34,282 shares @ $3.66, valued at $125.5k
10/29/2021 4 Volkart Carmen B (Director) has filed a Form 4 on ANTARES PHARMA, INC.
Txns: Granted 55,916 options to buy @ $3.48, valued at $194.6k
10/29/2021 3 Volkart Carmen B (Director) has filed a Form 3 on ANTARES PHARMA, INC.
08/31/2021 4 JACOB LEONARD S (Director) has filed a Form 4 on ANTARES PHARMA, INC.
Txns: Granted 24,679 shares @ $2.24, valued at $55.3k
Paid exercise price by delivering 13,820 shares @ $4, valued at $55.3k
Exercised 24,679 options to buy @ $2.24, valued at $55.3k
07/09/2021 4 GUETH ANTON (Director) has filed a Form 4 on ANTARES PHARMA, INC.
Txns: Sold 100,000 shares @ $4.29, valued at $429k
06/14/2021 4 Smith Karen L. (Director) has filed a Form 4 on ANTARES PHARMA, INC.
Txns: Granted 25,452 shares @ $4.42, valued at $112.5k
Granted 48,542 options to buy @ $4.42, valued at $214.6k
06/14/2021 4 ROCHE ROBERT P JR (Director) has filed a Form 4 on ANTARES PHARMA, INC.
Txns: Granted 25,452 shares @ $4.42, valued at $112.5k
Granted 48,542 options to buy @ $4.42, valued at $214.6k
06/14/2021 4 Richardson Peter C (EVP, R&D Chief Medical Officer) has filed a Form 4 on ANTARES PHARMA, INC.
Txns: Granted 36,199 shares @ $4.42, valued at $160k
Granted 69,037 options to buy @ $4.42, valued at $305.1k
06/14/2021 4 Powell Fred M (Executive Vice President & CFO) has filed a Form 4 on ANTARES PHARMA, INC.
Txns: Granted 85,973 shares @ $4.42, valued at $380k
Paid exercise price by delivering 17,327 shares @ $4.45, valued at $77.1k
Paid exercise price by delivering 11,880 shares @ $4.45, valued at $52.9k
Granted 163,963 options to buy @ $4.42, valued at $724.7k
06/14/2021 4 JACOB LEONARD S (Director) has filed a Form 4 on ANTARES PHARMA, INC.
Txns: Granted 31,674 shares @ $4.42, valued at $140k
Granted 60,407 options to buy @ $4.42, valued at $267k
06/14/2021 4 GUETH ANTON (Director) has filed a Form 4 on ANTARES PHARMA, INC.
Txns: Granted 25,452 shares @ $4.42, valued at $112.5k
Granted 48,542 options to buy @ $4.42, valued at $214.6k
06/14/2021 4 Greenleaf Peter (Director) has filed a Form 4 on ANTARES PHARMA, INC.
Txns: Granted 25,452 shares @ $4.42, valued at $112.5k
Granted 48,542 options to buy @ $4.42, valued at $214.6k
06/14/2021 4 GRAHAM PETER J (EVP General Counsel, Secretary) has filed a Form 4 on ANTARES PHARMA, INC.
Txns: Granted 85,973 shares @ $4.42, valued at $380k
Paid exercise price by delivering 23,010 shares @ $4.45, valued at $102.4k
Paid exercise price by delivering 14,790 shares @ $4.45, valued at $65.8k
Granted 163,963 options to buy @ $4.42, valued at $724.7k
06/14/2021 4 GARRITY THOMAS J (Director) has filed a Form 4 on ANTARES PHARMA, INC.
Txns: Granted 25,452 shares @ $4.42, valued at $112.5k
Granted 48,542 options to buy @ $4.42, valued at $214.6k
06/14/2021 4 APPLE ROBERT F (President & CEO) has filed a Form 4 on ANTARES PHARMA, INC.
Txns: Granted 248,869 shares @ $4.42, valued at $1.1M
Paid exercise price by delivering 58,317 shares @ $4.45, valued at $259.5k
Paid exercise price by delivering 40,892 shares @ $4.45, valued at $182k
Granted 474,629 options to buy @ $4.42, valued at $2.1M
06/10/2021 4 Powell Fred M (Executive Vice President & CFO) has filed a Form 4 on ANTARES PHARMA, INC.
Txns: Paid exercise price by delivering 12,045 shares @ $4.39, valued at $52.9k
06/10/2021 4 GRAHAM PETER J (EVP General Counsel, Secretary) has filed a Form 4 on ANTARES PHARMA, INC.
Txns: Paid exercise price by delivering 15,996 shares @ $4.39, valued at $70.2k
06/10/2021 4 APPLE ROBERT F (President & CEO) has filed a Form 4 on ANTARES PHARMA, INC.
Txns: Paid exercise price by delivering 44,223 shares @ $4.39, valued at $194.1k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy